Galmed Pharma (GLMD) Misses Q3 EPS by 25c
Galmed Pharma (NASDAQ: GLMD) reported Q3 EPS of ($0.62), $0.25 worse than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.
Galmed Pharma (NASDAQ: GLMD) reported Q3 EPS of ($0.62), $0.25 worse than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.